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Abstract
Acoustic radiation force impulse (ARFI) Surveillance of Subcutaneous Hemorrhage (ASSH) has 
been previously demonstrated to differentiate bleeding phenotype and responses to therapy in dogs 
and humans, but to date, the method has lacked experimental validation. This work explores 
experimental validation of ASSH in a poroelastic tissue-mimic and in vivo in dogs. The 
experimental design exploits calibrated flow rates and infusion durations of evaporated milk in 
tofu or heparinized autologous blood in dogs. The validation approach enables controlled 
comparisons of ASSH-derived bleeding rate (BR) and time to hemostasis (TTH) metrics. In tissue-
mimicking experiments, halving the calibrated flow rate yielded ASSH-derived BRs that 
decreased by 44% to 48%. Furthermore, for calibrated flow durations of 5.0 minutes and 7.0 
minutes, average ASSH-derived TTH was 5.2 minutes and 7.0 minutes, respectively, with ASSH 
predicting the correct TTH in 78% of trials. In dogs undergoing calibrated autologous blood 
infusion, ASSH measured a 3-minute increase in TTH, corresponding to the same increase in the 
calibrated flow duration. For a measured 5% decrease in autologous infusion flow rate, ASSH 
detected a 7% decrease in BR. These tissue-mimicking and in vivo preclinical experimental 
validation studies suggest the ASSH BR and TTH measures reflect bleeding dynamics.
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Introduction
Prolonged or undetected bleeding can increase the risk of mortality and morbidity in patients 
with disordered bleeding, whether induced or inherited. Induced disordered bleeding often 
results from the introduction of anticoagulants prior to invasive surgical procedures1,2. After 
surgical procedures, clinically standard care may be blind to subcutaneous bleeding, despite 
available therapies if excessive bleeding is diagnosed3,4. Analysis of subcutaneous bleeding 
dynamics could lead to diagnoses that improve patient outcomes, but this analysis requires 
an in vivo subcutaneous bleeding detection method. Additionally, inherited disordered 
bleeding, as with hemophilia A or von Willebrand’s disease, requires lifelong therapy and 
management5. Advances in treatment would benefit from the development of improved 
pharmacotherapies to control bleeding response. Accurately assessing bleeding response for 
the development of pharmacotherapies requires an analysis method that is in vivo, 
reproducible, and validated. Differentiating bleeding phenotype is an important tool in the 
development and testing of pharmacotherapies, and assessing the subcutaneous bleeding 
dynamics is diagnostically relevant, but there is currently no reproducible method to assess 
in vivo bleeding dynamics available.
Commonly used first-line clotting tests to evaluate bleeding risk in patients include activated 
partial thromboplastin time (APTT) and prothrombin time (PT). Both APTT and PT are in 
vitro measures that require the introduction of exogenous reagents, and thus do not 
accurately reflect in vivo bleeding response1,6,7. Alternatively, standardized skin bleeding 
time (BT) is an in vivo hemostasis test that can be performed, but this method suffers from a 
lack of reproducibility and heavy reliance on testing location1,8,9,10. Other tests have been 
developed to evaluate primary hemostasis, but these are not widely used or validated1,11. 
Currently, there is no reproducible method to assess in vivo bleeding dynamics available, 
which creates a need for an in vivo hemorrhage detection method.
A novel hemorrhage detection method, ARFI Surveillance of Subcutaneous Hemorrhage 
(ASSH), uses acoustic radiation force (ARF) impulses to induce displacement in soft tissue 
and conventional ultrasonic tracking pulses to monitor the displacement response. Tissue 
containing hemorrhage exhibits heightened displacement variance, which is evaluated as the 
variance of the second time-derivative of displacement following soft tissue recovery, as 
described in Scola et al12. Thus, placing an adaptive threshold on the variance identifies 
pixels corresponding to regions of hemorrhage, and the area of hemorrhage is measured 
through several serially-acquired imaging frames over time. Then, metrics describing 
bleeding dynamics, bleeding rate (BR) and time to hemostasis (TTH), are measured as the 
rate of change in the detected hemorrhagic area and the time at which the rate decreases to 
zero, respectively.
We have previously shown that ASSH-derived BR and TTH metrics differentiate bleeding 
phenotype in dogs with hemophilia A and von Willebrand disease in naive versus treated 
states and versus control dogs with no known bleeding disorders12,13,14. We have also 
demonstrated that ASSH distinguishes BR and TTH at femoral arteriotomy following 
diagnostic percutaneous coronary catheterization in humans treated with standard of care 
manual compression alone versus standard of care augmented by hemostatic dressing15.
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Although our previous body of work demonstrates that ASSH-derived BR and TTH 
measures are consistent with expected variation with phenotype and/or treatment, the lack of 
an alternative, validated method for direct measurement of subcutaneous bleeding dynamics 
has precluded in vivo ASSH validation. If not in the context of true in vivo bleeding, the 
purpose of this study is to experimentally validate ASSH BR and TTH measures using 
calibrated flow rates and durations in tissue-mimicking materials and in dogs, in vivo.
This work explores an experimental validation of this method, utilizing tofu as a tissue 
mimicking model and animal trials. In previous research, tofu has been examined as a 
poroelastic tissue mimic16,17,18, with similar speed of sound and without the effect of 
experiencing any rigor expected with deceased animal tissue. Evaporated milk has been 
shown to have properties suited for use as a blood mimic, while avoiding the clotting 
properties of blood 19,20,21,22. The animal trials, utilizing dogs with no known bleeding 
abnormalities, infused native blood from a femoral artery puncture into an avascular space. 
To slow clotting on artificial surfaces, the dogs were intravenously heparinized.
Method
Infusing Evaporated Milk into Tofu
Figure 1 demonstrates the experimental setup for infusing evaporated milk into tofu. For 
each trial, tofu (Vitasoy Firm) samples were weighed and placed in a water bath, in Figure 
1D. Concurrently, evaporated milk (My Essentials) was mixed with food dye, Figure 1B. 
With B-mode ultrasound guidance (Figure 1A), a 20 gauge catheter sheath connected to the 
reservoir of dyed evaporated milk was inserted into the tofu at the approximate focus depth 
(2cm) and at the approximate lateral center of the 1.4cm imaging window. The imaging 
transducer was then displaced approximately 3 mm in elevation to avoid imaging 
interference from the catheter.
A peristaltic pump (Cole Parmer Masterflex L/S 7550-30 with Masterflex L/S Easy-Load II 
Head 77200-60, Figure 1C) was used to transfer the solution into tofu through a 20 gauge 
catheter sheath at controlled rates. Three combinations of programmed flow rates and 
durations were examined: 5.0 ml/min for 5.0 min, 2.5 ml/min for 5.0min, and 5.0 ml/min for 
7.0 min. Each of the three combinations of programmed flow rates and duration underwent 6 
repeated measures in separate trials, for 18 total experiments.
ARFI imaging was manually synchronized to the start of the flow pump, and an ARFI frame 
was acquired every minute for 12 minutes. For ARFI imaging, ARF impulses were centered 
at 4.21 MHz with an F/1.5 focal configuration and were 300 cycles (70 μs) in duration. 
Tracking pulses were centered at 6.15 MHz with an F/1.5 focal configuration and were 2 
cycles in duration. ARFI beam sequences consisted of an ARF excitation preceded by at 
least two tracking lines for reference and followed by 58 tracking lines in the region of ARF 
excitation. This beam sequence was applied in 40 lateral positions spaced 0.35 mm apart, 
spanning a 1.4 cm lateral field of view, by alternating the region of excitation from the left to 
the right side of the image frame. Imaging was conducted using a Siemens Acuson Antares 
imaging system specially equipped for research purposes and a VF7-3 linear array (Siemens 
Medical Solutions USA Inc, Ultrasound Division).
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Calibrated Autologous Infusion in Dogs
ASSH imaging was performed to monitor calibrated infusions of heparinized autologous 
blood in two dogs. (All animal trials received prior approval by the University of North 
Carolina at Chapel Hill Institutional Animal Care & Use Committee.)
Each dog was anesthetized. Typically, dogs are pre- medicated with atropine (0.022 – 0.044 
mg/kg SQ, IM) and butorphanol (0.2 – 0.4 mg/kg IM, SQ, or IV) for sedation, and then 
anesthesia is induced with propofol (“Propoflo” per manufacturer label at 5.5 mg/kg IV or 
“Propoflo28” per manufacturer label at 7.6 mg/kg IV) over 60 to 90 seconds followed by 
immediate intubation and transition to isoflurane to effect (~2%). Anesthesia is evaluated by 
heart rate, respiratory rate, blood pressure, oxygen saturation, end-tidal CO2, and persistence 
or absence of palpebral, corneal and withdrawal reflexes. In addition, body temperature is 
monitored and maintained with warming blankets as needed.
The dog was positioned in dorsal recumbancy. Overlying fur is shaved from each hind limb 
leg and the skin is cleaned in an aseptic fashion with alcohol and betadine. Heparin (35 
units/kg) was administered intravenously to prevent clotting during infusion.
The experimental setup is depicted in a flow chart and diagram shown in Figure 2. Similarly, 
a picture of the experimental setup is shown in Figure 3. With B-Mode ultrasound guidance, 
the right femoral artery was cannulated with a 5F arterial sheath (Figure 2A, Figure 3A), and 
a stopcock was positioned at the catheter to selectively stop or allow blood flow out of the 
artery. A catheter was also inserted using B-Mode guidance into peri-femoral muscle in the 
left hind limb (Figure 2D, Figure 3D), with particular attention given to avoiding obvious 
vasculature in the region. The puncturing needle and catheter were filled with saline prior to 
insertion to prevent introducing air bubbles into the muscle tissue. The imaging transducer 
(Figure 2E, Figure 3E), held in position using a stereotactic clamp (Figure 2F, Figure 3E), 
was then displaced approximately 5 mm in elevation to avoid imaging interference from the 
catheter.
With both catheters in place, one in the right femoral and the other in peri-femoral muscle in 
the left hind leg, sterile tubing with non-hemolytic properties (MasterFlex PharMed BPT 
L/S #13, Figure 3C) was first filled with saline (to prevent the introduction of air bubbles 
into the closed system) and then connected to the stopcock. The tubing was fed through a 
computerized peristaltic flow pump (Masterflex L/S with Easy-Load II Head, Figure 3B), 
which controlled the flow rate and duration. The flow pump was programmed for a flow rate 
of 5.0 ml/min, but the actual flow rate was calibrated by pumping blood into a graduated 
cylinder for 1 min. Programmed flow rates of 5.0mL were found to not clot for 7–10 minute 
trials, but lower rates produced clots in tubing. We observed that the actual flow rates were 
higher than the programmed rates, which may be attributable to arterial pressure. After flow 
rate calibration, the open end of the tubing was connected to the catheter inserted in the peri-
femoral muscle in the left hind limb. In this manner, when the stopcock was released and the 
flow pump enabled, heparinized autologous blood flowed from the femoral artery in the 
right hind limb into the peri-femoral muscle in the left hind limb via the peristalitic pump. 
Two durations were examined: 5.0 ml/min for 10.0min, and 5.0 ml/min for 7.0 min.
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ARFI imaging was manually synchronized to the start of the flow pump, and an ARFI frame 
was acquired every minute for 20 minutes. ARFI imaging sequences were not altered from 
sequences used on tofu. Imaging was conducted using a Siemens Acuson Antares imaging 
system specially equipped for research purposes and a VF7-3 linear array (Siemens Medical 
Solutions USA Inc, Ultrasound Division).
Data Processing
Acquired raw radio frequency data were transferred to a separate workstation for post 
processing using custom ASSH software. The ASSH algorithm, as previously described by 
Scola et al 12, began by calculating ARFI-induced axial displacement profiles using 1-D 
normalized cross-correlation. Then, from these profiles, the variance of the second time 
derivative of displacement (acceleration) after time to soft tissue recovery (~ 4 ms) was 
calculated for each pixel experiencing peak displacement of at least 3 μm. The variance of 
acceleration (VoA) values were then organized into a histogram with finely sampled bins to 
identify the VoA peaks, which corresponded to VoAs achieved in tofu/soft tissue not 
containing hemorrhage. The upper bound on these peaks defined an initial lower VoA 
threshold for ASSH. Another local peak in the high VoA range of the histogram, associated 
with noise, was also identified to initialize an upper VoA threshold for ASSH.
With initial VoA thresholds selected, pixels with VoA values between the lower and upper 
VoA thresholds were considered to contain hemorrhage. Similarly, those pixels with VoA 
values outside the range of the lower and upper VoA thresholds was considered to not 
contain hemorrhage. In this manner, a binary image was created, encoding each pixel in the 
field of view as hemorrhage or not hemorrhage. Next, the initial VoA thresholds were 
iteratively updated using the constraint that the detected region of hemorrhage should be 
contiguous through space and time, and a final region of hemorrhage was detected using the 
updated VoA thresholds.
With region of hemorrhage identified, hemorrhagic area was calculated using the area 
ascribed to each pixel for each ARFI frame in the serial acquisitions. Then, rate of change in 
hemorrhagic area over time of serial acquisition was calculated using local (3 min sliding 
window) linear regression, and positive rate of change in hemorrhagic area was used as a 
metric for bleeding rate (BR). The time at which the BR stabilized to ≤ 0 mm2/min for at 
least 5 min was considered the time to hemostasis onset (TTH).
ASSH BR and TTH were compared to the known flow rates of evaporated milk/blood and 
the known times at which the peristaltic pump was stopped.
Results
A representative ASSH imaging result in tofu is depicted in Figure 4. Panel (a) shows pixels 
identified as hemorrhagic (blue) superimposed on the corresponding B-Mode image. In 
panel (b), the identified hemorrhagic pixels are superimposed on a photograph of the tofu 
cross-section in the ASSH field of view. This tofu plane was matched to the ASSH imaging 
plane using fiducial markers, which are apparent in the B-Mode and tofu images 
(hyperechoic points numbered 1–7). For clarity, the tofu cross-section is shown without 
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ASSH hemorrhagic pixels superimposed to better depict the mimicked region of 
hemorrhage, indicated by the red dyed evaporated milk. Note that the axial range of ASSH 
imaging is limited to approximately 10 mm around the focus by the restriction that ASSH 
analysis be performed on pixels experiencing at least 3 microns of ARFI-induced peak 
displacement (see ‘Data Processing’ above).
Representative scatter plots of ASSH area of hemorrhage versus time for each of the three 
examined calibrated flow protocols are shown in Figure 5A. To facilitate visual 
comparisons, for each trial, the lowest detected hemorrhage area across all time was 
subtracted from the hemorrhagic area at each time point, such that each trial’s minimum 
ASSH detected hemorrhage area was normalized to 0 mm2. Importantly, this manner of 
normalization by subtraction did not impact the ASSH BR or TTH measurements. Note that 
for all three protocols, the ASSH area of hemorrhage increases over time to a peak 
hemorrhagic area and then decreases over time thereafter. This inflection point (circled) 
corresponds to the time at which the ASSH BR stabilizes to ≤ 0 mm2/min, which is noted as 
the ASSH TTH (see ‘Data Processing’ in the Methods section above). Note that for 
protocols 1, 2, and 3 the ASSH-derived TTHs are respectively 5, 5, and 7 min, consistent 
with the programmed flow durations.
In addition to TTH, the ASSH hemorrhagic area versus time curves shown in 5(a) encode, as 
the positive rate of change in hemorrhagic area over time, the ASSH BR metric. Note that 
protocols 1 and 3, with matched infusion rates of 5.0 ml/min, exhibit similar positive rates of 
change in the ASSH detected hemorrhagic area. On the contrary, protocol 2, with an 
infusion rate half that of protocols 1 and 3, exhibits a slower positive change in ASSH 
hemorrhagic area over time. A final observation from Figure 5(a) is that the ASSH-derived 
area of hemorrhage decreased after the infusion stop, which we attribute to diffusion of 
evaporated milk into the surrounding tofu media. We note that such milk diffusion after 
infusion stop may have resulted in the larger dyed area in Figure 4C.
The box plots shown in figure 5(b) further represent all ASSH BR values measured in the 
calibrated tofu experiments for the three protocols. The mean BRs are approximately 3.1 
mm2/min, 1.6 mm2/min, and 2.9 mm2/min, for protocols 1, 2, and 3, respectively. In these 
tissue-mimicking experiments, halving the calibrated flow rate yielded ASSH-detected BRs 
that decreased by 44–48%. Statistical significance was found between the ASSH-derived BR 
between Protocol 1 and Protocol 2 (Wilcoxon Ranksum, α<0.01) and between Protocol 2 
and Protocol 3 (Wilcoxon Ranksum, α<0.01). No statistically significant difference was 
found between ASSH BRs for protocols 1 and 3, which had matched infusion rates.
Figure 5(c) depicts all ASSH TTH measures for the three calibrated flow protocols against 
the known infusion time. For protocols 1 and 2, ASSH TTH matched the infusion duration 
in four out of six trials and was within ±1 minute of the true infusion duration in 2 out of six 
trials. For protocol 3, ASSH TTH matched the experimental infusion duration in six out of 
six trials. Overall, ASSH-detected TTH and known infusion time matched in 78% of all 
trials, while the remaining trials had ±1 minute error from the known infusion time. We note 
that with a temporal sampling period of 1 minute, a ±1 minute error is a single time sample 
offset from the true infusion stop. We attribute this ASSH TTH error, at least in part, to 
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manually synchronizing imaging and peristaltic pump starts. The average ASSH-detected 
TTH was 5.2 min and 7.0 min for trials with known infusion times of 5.0 min and 7.0 min, 
respectively.
Figure 6 depicts ASSH-detected hemorrhagic area versus time scatter plots for the two 
heparinized autologous blood infusion trials in dogs, in vivo. For each trial, the lowest 
detected hemorrhagic area was normalized by subtraction, as described above, to facilitate 
visual comparisons. ASSH area of hemorrhage increases initially to a peak value and then 
decreases. The peak (circled) corresponds to the time at which the ASSH-derived BR 
stabilizes to ≤ 0 mm2/min, which is the ASSH TTH. For these two in vivo dog trials, ASSH-
derived TTH was measured as 11 and 8 min, while the infusion stop time was 10 and 7 min, 
respectively. As was described above, we attribute this one-minute error in the TTH 
measurement to manual synchronization error. Note that the ASSH temporal sampling 
period was 1 min. Further, we attribute the decrease in ASSH hemorrhagic are after the 
infusion stop to diffusion of blood away from the ASSH imaging plane. In addition to TTH, 
the ASSH hemorrhagic area versus time graphs encode the ASSH BR, which was measured 
as 4.0 mm2/min for trial 1 and 3.7 mm2/min for trial 2. Table 1 summarizes the results of the 
autologous blood infusion trials. For the 5% decrease in the measured blood infusion rate 
between Trial 1 and Trial 2, the ASSH-detected BR decreased by 7%. Additionally, the 3 
min difference in blood infusion durations between trials was exactly measured by ASSH 
TTH.
Discussion
The data presented in this study demonstrate the feasibility of using ASSH as a non-invasive 
in vivo method to describe bleeding dynamics.
In the first part of this work, tofu was used as a porous tissue-mimicking material and 
infused with evaporated milk as a blood mimic. In Figure 4, the area of red-dyed milk in the 
tofu cross-section is larger than detected area of hemorrhage in the corresponding ASSH 
imaging plane, which could be related to three factors. First, the VoA thresholds used for 
ASSH hemorrhage detection may have been set such that ASSH missed hemorrhagic pixels 
with low VoA, which would be expected in regions with lower ARFI displacement further 
from the ARFI focal depth. Second, the ASSH field of view is axially constrained to the 
region in which ARFI-induced displacements are ≥ 3 μm. Therefore, mimicked hemorrhage 
located outside of this region (approximately 10 mm around the axial focal depth) is not 
interrogated by ASSH. Third, milk diffusion may have resulted in an expanded dyed region 
at the time the tofu was sectioned (approximately 10 minutes after the time of the 
corresponding ASSH image).
For the calibrated tofu and milk studies, halving infusion rate resulted in a 44–48% decrease 
in ASSH-detected BR, which is significant at the α<0.01 level (Wilcoxon Ranksum). This 
indicates that the ASSH BR metric is sensitive to reduction in infusion rate in this medium. 
Additionally, the TTH metric was examined in relation to the known infusion time. The 
ASSH-detected TTH matched the known infusion time in 78% of trials, with remaining 
trials having ±1 minute, or one temporal sampling unit, of error. This discrepancy may be 
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the result of synchronization error, as the starts of the flow pump and ASSH data 
acquisitions were manually synchronized.
Notably, tofu within a water bath is not susceptible to the same geometric constraints as in 
vivo tissue, which allowed the evaporated milk to slowly leak into the surrounding water 
bath. This slow leakage may have resulted in a lower than expected concentration of blood 
mimic within the imaging region. Additionally, evaporated milk does not clot. This 
experiment benefits from lack of clotting through consistent flow throughout infusion 
duration, but clotting is a critical factor in true bleeding dynamics in vivo. A non-clotting 
blood mimic was selected in this validation experimental setup specifically to allow a 
constant infusion rate.
In the second part of this work, native heparinized blood was infused in vivo into a peri-
femoral avascular space in an anesthetized dog. Two trials were performed at similar 
infusion rates, with a three-minute difference in infusion times. Although the infusion rates 
were similar, ASSH-detected BR reflected the small difference in infusion rates. This could 
indicate that the ASSH BR metric is sensitive to even small differences in infusion rate, but 
more investigation is needed to calibrate the degree of error in ASSH BR measures. The 
three-minute difference in infusion time was reflected in the ASSH-detected TTH metrics. 
For both dog trials, TTH was overestimated by approximately one minute. As described 
above, this error may be related to manually synchronizing the starts of the flow pump and 
ASSH data acquisitions.
It is important to consider that in both tofu and dog studies, the ASSH-detected region of 
hemorrhage was observed to decrease after the infusion stop time. We attribute this decrease 
to diffusion of milk/blood away from the ASSH imaging plane. Such diffusion has the 
potential to impact ASSH performance. If the rate of diffusion out of the ASSH imaging 
plane exceeds the rate of bleeding into the ASSH imaging plane, such that the overall ASSH 
hemorrhagic area decreases over time despite on-going bleeding, ASSH will falsely detect 
hemostasis. Moreover, for rates of diffusion away from the ASSH imaging plane that are 
less than but comparable to the rate of bleeding into the ASSH imaging plane, ASSH-
derived BR will be underestimated. The experiments conducted herein involved infusion 
rates (2.5 – 5.6 ml/min) that were two orders of magnitude smaller than the volume flow rate 
of blood in the human femoral artery (350 ml/min)28 Even for these very slow infusion rates, 
the diffusion of milk/blood away from the ASSH imaging plane did not inhibit ASSH from 
appropriately estimating TTH (within ± the one-minute temporal sampling unit) or relative 
differences in BR. Therefore, it is expected that ASSH will be clinically relevant for 
monitoring hemostasis at femoral artery punctures, such as those experienced with 
percutaneous coronary catheterization. However, ASSH’s application to monitoring 
substantially lower rates of hemorrhage, for example from much smaller vessels, may be 
challenged by diffusion rate.
The most notable limitation of this body of work is the small number of experiments. 
Despite the small number, significant differences were seen in the tissue mimicking 
experiments, with promising in vivo results. Another potential shortcoming was the limited 
axial ASSH range (approximately 10 mm surrounding the focal depth), which was imposed 
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by requiring that the detected ARF-induced peak displacement be ≥ 3 microns. Future work 
will expand ASSH’s axial range. Finally, ASSH BR was estimated using local (3-minute 
sliding window) linear regression applied to the derived ASSH hemorrhagic area versus time 
curves, but a nonlinear polynomial regression may achieve superior performance. This will 
be a topic of future investigation. Overall, this work demonstrates the feasibility of ASSH 
BR and TTH metrics for detecting changes in calibrated infusion rates and infusion times in 
a tissue mimicking model and in dogs, in vivo.
Conclusion
This pilot work demonstrates that changes in calibrated infusion rates and durations are 
reflected in ASSH-derived BR and TTH metrics. In a tofu and evaporated milk hemorrhage 
mimicking model, halving the infusion rate resulted in a 44–48% reduction in ASSH-
detected BR (Wilcoxon Ranksum, α<0.01), and ASSH correctly assigned TTH in 78% of 
trials. In an in vivo dog model of hemorrhage, a 5% reduction in flow rate was reflected in 
7% decrease in ASSH-detected BR, and a three-minute increase in flow duration was 
accurately measured by ASSH TTH. In all tissue-mimicking and dog trials in these studies, 
ASSH detected TTH was within 1 minute, corresponding to 1 time sampling interval, of the 
known infusion time. These data suggest that ASSH-derived BR and TTH metrics 
characterize hemorrhage dynamics.
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Figure 1. 
A. Bmode image of lateral and elevational fiducial markers in tofu B. Evaporated milk and 
red food dye is drawn through L/S #13 tubing driven by C. the Masterflex L/S Peristaltic 
pump with easy-load head. D. L/S #13 tubing connects to the 18F sheath inserted into tofu 
for infusion, imaged by the VF7-3. transducer.
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Figure 2. 
Flow chart and diagram of experimental setup. Once the dog is anesthetized, heparinized, 
and in dorsal recumbancy, (A) femoral artery access is gained in the right hind limb. (B) The 
Masterflex L/S Peristaltic pump with easy-load head pumps native arterial blood through (C) 
Non-hemolytic sterile L/S #13 tubing. (D) A VF7-3 transducer provides Bmode guidance 
used to place the 5F catheter sheath into avascular space in the left hind limb prior to ASSH 
data acquisitions. The same transducer is then used for ASSH imaging. (E) The transducer is 
encased in a sterile cover, and (F) a stereotactic clamp holds the encased transducer.
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Figure 3. 
Picture of experimental setup of dog in dorsal recumbancy shows (a) catheter with femoral 
artery access in right hind limb connected to (b) sterile L/S #13 tubing, driven by the 
peristaltic pump. The tubing is connected by (c) the stopcock to (d) the catheter in an 
avascular space in the left hind limb. This avascular space is imaged with (e) a VF7-3 
transducer with sterile transducer cover held by a stereotactic clamp.
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Figure 4. 
(a) ASSH-detected binary image(blue) at infusion stop time overlaid on associated Bmode 
with fiducial markers 1–7 (b) Aligned ASSH and Bmode with gross tofu photo, including 
fiducial markers 1–7 (c) tofu photo with fiducial markers 1–7. In images a–c, lateral ASSH 
field of view is indicated with solid vertical lines, and axial ARF focus is indicated with 
dashed horizontal lines.
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Figure 5. 
(a) A representative example of ASSH-detected hemorrhage area versus time in tofu for 
each of Protocol 1 (5mL/min for 5.0min- green circle), Protocol 2 (2.5mL/min for 5.0 min- 
red triangle) and Protocol 3 (5mL/min for 7.0 min- blue square). For each example trial, 
ASSH hemorrhagic areas at the measured TTH are indicated with a dashed circle. Lowest 
detected area was normalized by subtraction to 0 mm2 for the 3 examples. (b) Box plots of 
mean positive ASSH BR before TTH, showing median (red line), 25th and 75th percentiles 
(blue box), and the range of observed values (black dashed lines) for each of three protocols. 
Statistical significance (α<0.01, Wilcoxon Ranksum, gray asterick) is indicated between 
Protocols 1 and 2, and between Protocols 2 and 3. (c) ASSH TTH detection for each of the 
three protocols. ASSH-detected TTH matched the calibrated flow duration (green) in 14/18 
total trials, and is off by the sampling period of 1 minute (gray) in the remaining 4/18 trials.
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Figure 6. 
ASSH-detected hemorrhagic area versus time for heparinized autologous blood infusion 
trials in dogs. Blood was infused into periarterial tissue at 5.6mL/min for 10 min (trial 1, 
blue squares) or 5.3mL/min for 7min (trial 2, red triangles). For both trials, the hemorrhagic 
area corresponding to the ASSH-derived TTH is circled. ASSH TTHs were 11 and 8 min for 
trials 1 and 2, respectively. Lowest detected area was normalized by subtraction to 0 mm2 to 
facilitate visual comparisons.
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Table 1
Heparinized Autologous Infusion
Flow Rate Flow Time ASSH BR ASSH TTH
Trial 1 5.6 mL/min 10.0 min 4.0 mm2/min 11.0 min
Trial 2 5.3 mL/min 7.0 min 3.7 mm2/min 8.0 min
Difference 0.3 mL/min (5%) 3.0 min 0.3 mm2/min (7%) 3.0 min
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